躁狂症和双相情感障碍发病率的上升：成因及潜在负面影响。
The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.
作者信息
Yutzy Sean H, Woofter Chad R, Abbott Christopher C, Melhem Imad M, Parish Brooke S
机构信息
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
出版信息
J Nerv Ment Dis. 2012 May;200(5):380-7. doi: 10.1097/NMD.0b013e3182531f17.
Abstract
The frequency of mania has not changed during the last century even with the development of new diagnostic criteria sets. More specifically, from the mid-1970s to 2000, the rate of mania (variably labeled major affective disorder-bipolar disorder and bipolar I disorder) was consistently identified in US and international studies as ranging from 0.4% to 1.6%. By the late 1990s to the 2000s, the prevalence reported by some researchers for bipolar disorders (I and II and others) was in the 5% to 7% and higher ranges. The purpose of this paper was to review explanations for this change and the potentially negative impacts on the field.
摘要
即使有了新的诊断标准集，在上个世纪躁狂症的发病率并未改变。更具体地说，从20世纪70年代中期到2000年，在美国和国际研究中，躁狂症（不同地标记为重度情感障碍 - 双相情感障碍和双相I型障碍）的发病率一直被确定为0.4%至1.6%。到20世纪90年代末至21世纪初，一些研究人员报告的双相情感障碍（I型和II型及其他类型）的患病率在5%至7%及更高范围。本文的目的是回顾对这一变化的解释以及对该领域可能产生的负面影响。
相似文献
1
The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.
J Nerv Ment Dis. 2012 May;200(5):380-7. doi: 10.1097/NMD.0b013e3182531f17.
2
Mania with and without depression in a community sample of US adolescents.
Arch Gen Psychiatry. 2012 Sep;69(9):943-51. doi: 10.1001/archgenpsychiatry.2012.38.
3
[Antipsychotics in bipolar disorders].
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
4
Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state.
Bipolar Disord. 2018 Jun;20(4):303-312. doi: 10.1111/bdi.12596. Epub 2018 Jan 25.
5
Strategies to reduce misdiagnosis of bipolar depression.
Psychiatr Serv. 2001 Jan;52(1):51-5. doi: 10.1176/appi.ps.52.1.51.
6
ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.
7
The latest mania: selling bipolar disorder.
PLoS Med. 2006 Apr;3(4):e185. doi: 10.1371/journal.pmed.0030185. Epub 2006 Apr 11.
8
Bipolar II disorder : epidemiology, diagnosis and management.
CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003.
9
Epidemiology and course of unipolar mania: results from the national epidemiologic survey on alcohol and related conditions (NESARC).
Depress Anxiety. 2014 Sep;31(9):746-55. doi: 10.1002/da.22261. Epub 2014 Mar 27.
10
[Crosscultural aspects of bipolar disorder: results of a comparative study between French and Tunisian patients].
Encephale. 2012 Jun;38(3):194-200. doi: 10.1016/j.encep.2011.04.003. Epub 2011 Oct 11.
引用本文的文献
1
Association between Sleep Quality and Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Bipolar Disorder.
Med J Islam Repub Iran. 2024 May 13;38:53. doi: 10.47176/mjiri.38.53. eCollection 2024.
2
Predictors of behavioral health unit readmission within 30 days of discharge: A retrospective study.
Heliyon. 2022 Sep 30;8(10):e10784. doi: 10.1016/j.heliyon.2022.e10784. eCollection 2022 Oct.
3
Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?
Evol Hum Behav. 2021 May;42(3):194-203. doi: 10.1016/j.evolhumbehav.2020.09.006. Epub 2020 Oct 1.
4
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.
Am J Psychiatry. 2020 Aug 1;177(8):706-715. doi: 10.1176/appi.ajp.2020.19091000. Epub 2020 Apr 21.
5
Inflammation in CNS neurodegenerative diseases.
Immunology. 2018 Jun;154(2):204-219. doi: 10.1111/imm.12922. Epub 2018 Apr 17.
6
Systematic Study of Structured Diagnostic Procedures in Outpatient Psychiatric Rehabilitation: A Three-year, Three-cohort Study of the Stability of Psychiatric Diagnoses.
Innov Clin Neurosci. 2013 May;10(5-6):14-9.
本文引用的文献
1
Factors associated with work, social life and family life disability in bipolar disorder patients.
Psychiatry Res. 2011 Apr 30;186(2-3):254-60. doi: 10.1016/j.psychres.2010.06.020. Epub 2010 Jul 19.
2
Overdiagnosis of bipolar disorder and disability payments.
J Nerv Ment Dis. 2010 Jun;198(6):452-4. doi: 10.1097/NMD.0b013e3181e084e1.
3
Questionable antipsychotic prescribing remains common, despite serious risks.
JAMA. 2010 Apr 28;303(16):1582-4. doi: 10.1001/jama.2010.453.
4
The efficacy, tolerability, and safety of contemporary antidepressants.
J Clin Psychiatry. 2010;71 Suppl E1:e03. doi: 10.4088/JCP.9058se1c.03gry.
5
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
Clin Ther. 2010;32 Suppl 1:S32-8. doi: 10.1016/j.clinthera.2010.01.022.
6
Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021.
7
2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.
Clin Toxicol (Phila). 2009 Dec;47(10):911-1084. doi: 10.3109/15563650903438566.
8
Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.
Br J Psychiatry Suppl. 2009 Nov;52:S13-9. doi: 10.1192/bjp.195.52.s13.
9
The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.
Drugs. 2009 Oct 22;69(15):2063-101. doi: 10.2165/11318850-000000000-00000.
10
Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder.
J Clin Psychiatry. 2010 Jan;71(1):26-31. doi: 10.4088/JCP.08m04633. Epub 2009 Jul 28.
Zotero 插件